The stock is trading below its 50-day moving average by 38.52%. Furthermore, shares of CEL-SCI, which …
Stock
CEL-SCI Corporation was a big mover last session, as the company saw its shares rise over 11% on the day. The stock rallied on the release of the company’s video summarizing phase 3 head and neck cancer …
ZACKS12mon
32,752 shares of the stock traded hands, up from an average trading volume of 23,892 Barclays PLC has …
Barclays
CEL-SCI Corporation (NYSE MKT: CVM), a late-stage oncology company, today announced that it has closed …
CEL-SCI Corporation (NYSE: CVM), a late-stage oncology company, today announced that it intends to offer and sell common stock and warrants, subject to market and other conditions, in an underwritten public offering. …
Cellcom Israel (NYSE:CEL) traded up 0.11% during trading on Thursday, hitting $9.53. 2,999 shares of the stock traded hands. Cellcom Israel has a 12 month low of $5.70 and a 12 month high of $10.17. The company has a …
Thecer1mon
Barclays
CEL-SCI Corporation (NYSE MKT:CVM) announced today that it has priced its public offering of common stock and warrants. CEL-SCI announced that it has agreed to sell 34,024,000 shares of common stock and warrants …
WFMJ2mon
Dec 2 Cel-Sci Corp : * Cel-Sci announces pricing of $4.25 million public offering of common stock and warrants * Has agreed to sell 34 million shares of common stock and warrants to purchase common stock at a price of …
Reuters
CEL-SCI Corporation (NYSE MKT: CVM) announced today that it intends to offer and sell, subject to market and other conditions shares of its common stock and warrants to purchase common stock. The securities are to …
VIENNA, Va.--(Business Wire)--CEL-SCI Corporation (NYSE MKT:CVM) announced today that it has priced its public offering of common stock and warrants. CEL-SCI announced that it has agreed to sell 34,024,000 …